Omega Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US68217N1054
USD
0.00
0 (50.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
58.02
105.97
200.63
10.60
-9.21
Shareholder's Funds
58.02
105.97
200.63
10.60
-9.21
Minority Interest
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
30.19
21.46
19.87
11.73
11.89
Secured Loans
30.19
21.46
19.87
11.73
11.89
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
104.66
1.46
0.85
1.05
1.21
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
119.54
18.06
20.72
9.79
13.10
Current Liabilities
Trade Payables
1.62
3.11
2.11
1.06
0.92
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
26.81
21.96
11.98
7.70
2.23
Total Liabilities
204.37
146.00
233.33
28.08
6.12
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
Gross Block
120.11
13.28
7.46
5.95
4.22
Less: Accumulated Depreciation
6.06
5.41
3.85
2.47
1.39
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
Net Block
114.05
7.86
3.60
3.48
2.83
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.34
0.34
0.34
0.34
0.34
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.09
0.20
0.10
0.26
0.29
Total Non-Current Assets
114.48
8.41
4.05
4.08
3.47
Current Assets Loans & Advances
Current Investments
4.99
54.06
38.84
0.00
0.00
Inventories
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
5.12
0.00
0.00
0.00
0.00
Cash and Bank
68.44
70.61
186.48
22.95
2.27
Other Current Assets
80.42
126.48
225.85
23.14
2.28
Short Term Loans and Advances
1.86
0.00
0.00
0.00
0.00
Total Current Assets
89.88
137.59
229.29
24.00
2.65
Net Current Assets (Including Current Investments)
63.08
115.63
217.30
16.30
0.43
Total Current Assets Excluding Current Investments
89.88
137.59
229.29
24.00
2.65
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
Total Assets
204.37
146.00
233.33
28.08
6.12
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
Total Debt
30.19
21.46
19.87
11.73
11.89
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2023 is -10.36% vs -16.46% in Dec 2022

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2023 is 7,068.49% vs 71.76% in Dec 2022

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2023 is 1,351.02% vs 118.33% in Dec 2022

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Dec 2023 is -34.68% vs -39.99% in Dec 2022

Compare Balance Sheet Results of Omega Therapeutics, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
58.02
52.48
5.54
10.56%
Shareholder's Funds
58.02
52.48
5.54
10.56%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
30.19
0.27
29.92
11,081.48%
Secured Loans
30.19
0.27
29.92
11,081.48%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
104.66
1.16
103.50
8,922.41%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
119.54
1.16
118.38
10,205.17%
Current Liabilities
Trade Payables
1.62
2.16
-0.54
-25.00%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
26.81
17.07
9.74
57.06%
Total Liabilities
204.37
70.71
133.66
189.03%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
120.11
8.10
112.01
1,382.84%
Less: Accumulated Depreciation
6.06
0.46
5.60
1,217.39%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
114.05
7.63
106.42
1,394.76%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0.34
0.06
0.28
466.67%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0.09
1.33
-1.24
-93.23%
Total Non-Current Assets
114.48
9.42
105.06
1,115.29%
Current Assets Loans & Advances
Current Investments
4.99
18.57
-13.58
-73.13%
Inventories
0
5.31
-5.31
-100.00%
Sundry Debtors
5.12
5.90
-0.78
-13.22%
Cash and Bank
68.44
28.67
39.77
138.72%
Other Current Assets
80.42
58.45
21.97
37.59%
Short Term Loans and Advances
1.86
0
1.86
0.00%
Total Current Assets
89.88
61.29
28.59
46.65%
Net Current Assets (Including Current Investments)
63.08
44.21
18.87
42.68%
Total Current Assets Excluding Current Investments
89.88
61.29
28.59
46.65%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
204.37
70.71
133.66
189.03%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
30.19
0.27
29.92
11,081.48%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 14.88 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is -10.36% vs -16.46% in Dec 2022

Annual - Other Long Term Liabilities
Other Long Term Liabilities 104.66 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 7,068.49% vs 71.76% in Dec 2022

Annual - Fixed Assets
Fixed Assets 114.05 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 1,351.02% vs 118.33% in Dec 2022

Annual - Investments
Investments 0.34 Million
in Dec 2023

Figures in Million
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 89.88 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is -34.68% vs -39.99% in Dec 2022